MSCI August Index Review Announcement Scheduled for August 12, 2026

MSCI Inc. (NYSE:MSCI) said it will announce the results of its August 2026 Index Review for multiple MSCI equity, value and growth, small cap, micro cap, frontier, REIT, and China A and All Shares indexes on Aug. 12, 2026. Changes will take effect after the close of Aug. 31, 2026, with additions and deletions posted on MSCI’s site.

Original reporting
Published Aug 5, 2026, 10:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 10:47 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
MSCI August Index Review Announcement Scheduled for August 12, 2026 — source image
Decision brief

The 30-second read

$MSCINeutralLow
01

Why it matters

The main tradable element is the timing of the constituent list release and the effective date, which can create mechanical demand/supply shifts for benchmarked securities.

02

Market read

This is a calendar-style disclosure for MSCI’s Aug 2026 index review, useful for planning around expected rebalancing flows once the constituent changes are published.

03

What to watch

Traders may need to focus on the specific index families and the effective date mechanics (Aug 31 close) rather than the announcement time alone.

Relevance 4/10Novelty 3/10Timing: Aug 12, 2026 after 11:00 p.m. CEST announcement; changes effective as of Aug 31 close.

Background

MSCI periodically runs index reviews that result in additions and deletions across multiple MSCI index families, with changes taking effect at a specified cutoff.

Company-level read

Ticker impact

$MSCINeutralMedium confidence
Context

MSCI schedules its August 2026 Index Review results for Aug 12, with index additions and deletions effective after Aug 31 close.

Expected impact

Likely modest, event-driven volatility in affected index constituents around the Aug 12 announcement and Aug 31 effective date, with limited direct impact on MSCI’s own fundamentals.

Evidence & confidence

No constituent list or methodology change is provided, only the timing and that changes become effective as of the Aug 31 close.

Market effects

Index-review-driven rebalancing can affect broad equity, small-cap, value/growth, REIT, and frontier-market baskets tied to MSCI methodologies.

Potential read-through to US equity and REIT constituents, plus MSCI China A and China All Shares constituents, depending on additions/deletions.

MSCI index changes can influence passive and benchmark-tracking flows across multiple regions and market-cap segments.

Counterpoint

Because the article provides only the schedule and not the actual additions/deletions, it may not justify trading until the constituent list is released.

Key entities

  • MSCI Inc.

    Provider of equity index products and decision-support tools; subject of the scheduled August 2026 Index Review announcement.

  • MSCI Equity Indexes

    Includes MSCI Global Standard, Global Small Cap, Micro Cap, Value/Growth, Frontier Markets, and related US/REIT and China A/All Shares indexes referenced in the notice.

Related articles

$MSCIMed

Transcript: MSCI Q2 2026 Earnings Conference Call

MSCI (NYSE:MSCI) reported Q2 2026 results on a conference call. The company said organic revenue growth was over 12%, adjusted EPS growth nearly 19%, and adjusted EBITDA growth 14%. It cited total run rate growth of 12%, ABF run rate growth of 25% to $948 million, and ETF-linked inflows of nearly $40 billion. MSCI repurchased $147 million of shares at about $558 average.

$SNDKMed

Stocks Gain as Chipmakers Rebound

Stocks rose as chipmakers and AI-infrastructure shares rebounded. The iShares Semiconductor ETF (SOXX) gained over 3%, while Sandisk (SNDK), Micron (MU), Western Digital (WDC), and others rose. Bitcoin hit a 1-month high, lifting Coinbase (COIN) and Circle (CRCL). Hasbro (HAS) reported Q2 net revenue $1.14B and raised guidance; 3M (MMM) beat EPS and lifted outlook.

$MSCIMed

MSCI-Linked ETF AUM Tops $2.8 Trillion, but Investors Still Sold the Stock - MSCI (NYSE:MSCI)

MSCI reported operating revenue of $867 million, up 12.2% year over year, slightly above expectations of $866.4 million, driven by higher recurring subscription and asset-based fees. MSCI-linked ETF AUM rose above $2.8 trillion on nearly $40 billion in Q2 inflows. Despite record inflows, MSCI shares fell about 10% Tuesday to $561.74. The company raised 2026 cash flow and expense outlooks.

$MSCIMedAI 8/10

Why MSCI Stock Is Plummeting Lower Today

MSCI shares fell about 10% to around $561.74 after the company reported Q2 results that missed Wall Street expectations, despite sales up 12% and adjusted EPS up 19%. MSCI also slightly raised 2026 expense guidance tied to integrating First Street. Investors are reacting to the earnings and guidance.

$MSCIMed

MSCI Q2 Earnings Call Highlights

MSCI reported Q2 results on its earnings call. CFO Andy Wiechmann said the asset-based fee run rate neared $950 million and ETF AUM linked to MSCI indexes rose to over $2.8 trillion. Management cited 17% index run rate growth, 41% recurring net new sales growth, and retention above 97%, plus Private Assets growth and AI product adoption. Sustainability and climate sales faced cancellations; guidance turned roughly zero to slightly negative.